Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TMC Life Sciences BhdXKLS:0101 61 EV-to-OCF is 13.90 as of Aug. 20, 2026, which is 46% below its 10-year median of 25.55. GuruFocus rates XKLS:0101 with a GF Score™ of 61/100 and a GF Value™ of RM0.63 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 682 Healthcare Providers & Services companies, TMC Life Sciences Bhd ranks worse than 66.13% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, TMC Life Sciences Bhd's Enterprise Value is RM839.3 Mil.
TMC Life Sciences Bhd's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was RM60.4 Mil. Therefore, TMC Life Sciences Bhd's EV-to-OCF for today is 13.90.
The historical rank and industry rank for TMC Life Sciences Bhd's EV-to-OCF or its related term are showing as below:
XKLS:0101'
s EV-to-OCF Range Over the Past 10 Years
Min: -1500.33 Med: 25.55 Max: 161.8
Current: 14.04
During the past 13 years, the highest EV-to-OCF of TMC Life Sciences Bhd was 161.80. The lowest was -1500.33. And the median was 25.55.
XKLS:0101's EV-to-OCF is ranked worse than 66.13% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 8.825
vs XKLS:0101: 14.04
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
TMC Life Sciences Bhd (XKLS:0101) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
TMC Life Sciences Bhd's PE Ratio (TTM) for today is calculated as:
TMC Life Sciences Bhd's share price for today is RM0.46.
TMC Life Sciences Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.009.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TMC Life Sciences Bhd EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where TMC Life Sciences Bhd's EV-to-OCF falls into.
TMC Life Sciences Bhd's current Enterprise Value is RM839.3 Mil.
TMC Life Sciences Bhd's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM60.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TMC Life Sciences Bhd (XKLS:0101) has a EV-to-OCF of 13.90 as of Aug. 20, 2026. This is 46% below median its historical median of 25.55. According to the industry distribution chart, TMC Life Sciences Bhd ranks #451 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 66.1%.
Is TMC Life Sciences Bhd's EV-to-OCF too high?
TMC Life Sciences Bhd's current EV-to-OCF of 13.90 is 46% below median its 10-year median of 25.55. The Healthcare Providers & Services industry median EV-to-OCF is 8.83. TMC Life Sciences Bhd's value of 13.90 is 57.5% above this industry median. Based on the distribution chart, TMC Life Sciences Bhd ranks #451 out of 682 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, TMC Life Sciences Bhd has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TMC Life Sciences Bhd's EV-to-OCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, TMC Life Sciences Bhd ranks #451 out of 682 companies for EV-to-OCF. This places TMC Life Sciences Bhd in the lower half of its industry. The industry median EV-to-OCF is 8.83. TMC Life Sciences Bhd's value of 13.90 is 57.5% above this benchmark. While the company's 10-year median is 25.55 vs. the industry median of 8.83, TMC Life Sciences Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.83, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TMC Life Sciences Bhd's current EV-to-OCF of 13.90 is 57.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TMC Life Sciences Bhd's current EV-to-OCF is 13.90, which is 46% below median its own 10-year median of 25.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMC Life Sciences Bhd stock overvalued right now?
Based on GuruFocus' analysis, TMC Life Sciences Bhd (XKLS:0101) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.63, compared to a current price of RM0.46 — trading 27% below its estimated fair value. The current EV-to-OCF is 13.90, which is 46% below median its 10-year median of 25.55 and 57.5% above the Healthcare Providers & Services industry median of 8.83. TMC Life Sciences Bhd's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For TMC Life Sciences Bhd (XKLS:0101), the current EV-to-OCF is 13.90 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TMC Life Sciences Bhd (XKLS:0101) Overvalued in 2026?
Based on GuruFocus' analysis, TMC Life Sciences Bhd stock appears to be undervalued.
The current stock price of RM0.46 is trading 27% below its estimated GF Value™ of RM0.63.
GuruFocus considers TMC Life Sciences Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0101:
EV-to-OCF: 13.90 (46% below median its 10-year median of 25.55)
GF Value™: RM0.63 vs. price of RM0.46 (27% below fair value)
Industry Position: 57.5% above the Healthcare Providers & Services median (#451 of 682)
No single metric tells the full story. See the XKLS:0101 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
61GF Score
Get the complete analysis for XKLS:0101
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0101 has been successfully added to your 
